|
?:authorAffiliation
|
-
[\'Rudolf Buchheim Institute of Pharmacology, Justus Liebig University, Giessen, Germany.\', \'Institute of Medical Virology, Justus Liebig University, Giessen, Germany.\', \'Mass spectrometry facility of the Department of Chemistry, Philipps University, Marburg, Germany.\', \'Institute of Medical Microbiology, Justus Liebig University, Giessen, Germany.\', \'German Center for Infection Research (DZIF), partner site Giessen-Marburg-Langen, Giessen, Germany.\', \'Bioinformatics and Systems Biology, Justus Liebig University, Giessen, Germany.\', \'Institute of Virology, Philipps University, Marburg, Germany.\', \'Department of Internal Medicine II for Pulmonary and Critical Care Medicine and Infectious Diseases, Justus Liebig University, and Institute for Lung Health (ILH), Giessen, Germany.\', \'German Center for Lung Research (DZL) and Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany.\', \'Institute of Biochemistry, Justus Liebig University, Giessen, Germany.\', \'Institute of Medical Virology, Justus Liebig University, Giessen, Germany. john.ziebuhr@viro.med.uni-giessen.de.\', \'German Center for Infection Research (DZIF), partner site Giessen-Marburg-Langen, Giessen, Germany. john.ziebuhr@viro.med.uni-giessen.de.\', \'Rudolf Buchheim Institute of Pharmacology, Justus Liebig University, Giessen, Germany. michael.kracht@pharma.med.uni-giessen.de.\', \'German Center for Lung Research (DZL) and Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany. michael.kracht@pharma.med.uni-giessen.de.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}